Literature DB >> 21165713

Target organ damage in a population at intermediate cardiovascular risk, with adjunctive major risk factors: CArdiovascular PREvention Sacco Study (CAPRESS).

Francesca Perego1, Elio Renesto, Massimo Arquati, Luciana Scandiani, Chiara Cogliati, Daniela Torzillo, Luca Zocchi, Giovanni Casazza, Piergiorgio Duca, Saverio Chirchiglia, Gemma Lacaita, Mauro Panteghini, Michele Cortellaro.   

Abstract

The objective of the study is to assess the prevalence of target organ damage (TOD) at carotid, cardiac, renal and peripheral vascular levels in a population at intermediate cardiovascular risk, with adjunctive major risk factors (AMRF). From March 2007 to July 2009 we examined 979 subjects at intermediate cardiovascular risk, as indicated by the Italian algorithm "Progetto Cuore"; the patients were aged 40-69 years, sensitized by one or more AMRF such as family history for cardiovascular disease (CVD), being overweight or obese, and smoking habit (more than 10 cigarettes/day). We measured common carotid intima-media thickness (cc-IMT) and plaque at any level, left ventricular mass index (LVMI), urine albumin/creatinine ratio (UACR), and ankle-brachial index (ABI). The prevalence of at least one TOD was 63% (617 subjects), cc-IMT was high in 48.2% (472), UACR abnormal in 14.1% (138), LVMI high in 12.6% (117) and ABI pathological in 9.1% (89). In those with carotid damage 423 had a plaque, amounting to 43.2% of the total population. Of note, carotid damage was present in all subjects with 3 TODs, and in 92% of subjects with 2 TODs. A multivariate logistic regression model including conventional factors and AMRF indicated that age 50-69 years, systolic blood pressure, relevant smoking and CV risk score ≥15 were independently and significantly associated with at least one TOD, and at least, with carotid damage. Among the AMRF, peripheral arterial disease was associated with relevant smoking, with an odds ratio (OR) of 3 [confidence interval (CI) 1.80-4.97, p < 0.0001]; overweight and obesity both had selective associations with cardiac damage with OR 2.75 (CI 1.2-6.3, p < 0.01) and OR 3.89 (CI 1.61-9.73, p < 0.01). A substantial proportion of people at intermediate risk, with at least one AMRF have at least one TOD, a major predictor of cardiovascular outcomes.

Entities:  

Mesh:

Year:  2010        PMID: 21165713     DOI: 10.1007/s11739-010-0501-7

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  39 in total

1.  Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests.

Authors:  P Greenland; S C Smith; S M Grundy
Journal:  Circulation       Date:  2001-10-09       Impact factor: 29.690

Review 2.  Cardiovascular risk prediction: basic concepts, current status, and future directions.

Authors:  Donald M Lloyd-Jones
Journal:  Circulation       Date:  2010-04-20       Impact factor: 29.690

3.  Does metabolic syndrome predict silent carotid stenosis in coronary patients?

Authors:  Marco Ambrosetti; Roberto F E Pedretti
Journal:  Intern Emerg Med       Date:  2008-02-19       Impact factor: 3.397

Review 4.  Evaluating cardiovascular risk assessment for asymptomatic people.

Authors:  Ian A Scott
Journal:  BMJ       Date:  2009-01-05

5.  Women with a low Framingham risk score and a family history of premature coronary heart disease have a high prevalence of subclinical coronary atherosclerosis.

Authors:  Erin D Michos; Chandrasekhar R Vasamreddy; Diane M Becker; Lisa R Yanek; Taryn F Moy; Elliot K Fishman; Lewis C Becker; Roger S Blumenthal
Journal:  Am Heart J       Date:  2005-12       Impact factor: 4.749

6.  Underlying risk factors incrementally add to the standard risk estimate in detecting subclinical atherosclerosis in low- and intermediate-risk middle-aged asymptomatic individuals.

Authors:  Milind Y Desai; Khurram Nasir; Joel B Braunstein; John A Rumberger; Wendy S Post; Matthew J Budoff; Roger S Blumenthal
Journal:  Am Heart J       Date:  2004-11       Impact factor: 4.749

7.  Which markers of subclinical organ damage to measure in individuals with high normal blood pressure?

Authors:  Thomas Sehestedt; Jørgen Jeppesen; Tine W Hansen; Susanne Rasmussen; Kristian Wachtell; Hans Ibsen; Christian Torp-Pedersen; Michael H Olsen
Journal:  J Hypertens       Date:  2009-06       Impact factor: 4.844

8.  Importance of obesity, race and age to the cardiac structural and functional effects of hypertension. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents.

Authors:  J S Gottdiener; D J Reda; B J Materson; B M Massie; A Notargiacomo; R J Hamburger; D W Williams; W G Henderson
Journal:  J Am Coll Cardiol       Date:  1994-11-15       Impact factor: 24.094

9.  Prevalence of conventional risk factors in patients with coronary heart disease.

Authors:  Umesh N Khot; Monica B Khot; Christopher T Bajzer; Shelly K Sapp; E Magnus Ohman; Sorin J Brener; Stephen G Ellis; A Michael Lincoff; Eric J Topol
Journal:  JAMA       Date:  2003-08-20       Impact factor: 56.272

10.  Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.

Authors:  Johan Arnlöv; Erik Ingelsson; Johan Sundström; Lars Lind
Journal:  Circulation       Date:  2009-12-28       Impact factor: 29.690

View more
  1 in total

1.  The unresolved challenge of subjects at intermediate cardiovascular risk.

Authors:  Alberto Tosetto
Journal:  Intern Emerg Med       Date:  2011-06-03       Impact factor: 3.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.